Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Hepatocellular × lobaplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 3 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Peritoneal Neoplasms 1 Liver, Cancer of, Primary Resectable 1 Hepatocellular Carcinoma Resectable 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Advanced Gastric Cancer 1 Acute Toxic Effects 1

Interventions

Sorafenib 187 lenvatinib 114 Bevacizumab 101 Nivolumab 73 pembrolizumab 64 atezolizumab 61 Radiosurgery 58 durvalumab 57 Oxaliplatin 53 Fluorouracil 50 sintilimab 45 Doxorubicin 41 apatinib 40 tislelizumab 35 Leucovorin 35 tremelimumab 34 camrelizumab 34 Radiofrequency Ablation 31 Radiotherapy 30 Magnetic Resonance Spectroscopy 27 Folfox protocol 26 Cyclophosphamide 25 Cisplatin 25 Capecitabine 25 Hepatectomy 24 cabozantinib 23 Ipilimumab 23 Gemcitabine 22 regorafenib 21 Ethiodized Oil 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02301091 2016-04-14

CORTT

Sun Yat-sen University

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡